Summit Trail Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Summit Trail Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,134	Closed	-$125K	–	259
2018 Q3	$125K	Buy	+2,134	New	+$109K	0.03%	245
2018 Q2	–	Sell	-7,393	Closed	-$234K	–	713
2018 Q1	$234K	Buy	7,393 +596	+9%	+$25K	0.04%	339
2017 Q4	$295K	Buy	+6,797	New	+$306K	0.04%	323

Other funds holding BSTC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Summit Trail Advisors's BSTC Position: Q4 2018 in Review

Summit Trail Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2018, closing a stake of 2,134 shares — an estimated $125K sold.

Summit Trail Advisors first reported a position in BSTC in Q4 2017 and held it in 3 quarters. The position peaked at $295K in Q4 2017. 107 funds tracked by Wall St. Rank hold BSTC as of Q4 2018.

Summit Trail Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2018 after selling out during the quarter.
Summit Trail Advisors sold 2,134 BioSpecifics Technologies Corp. shares in Q4 2018, an estimated $125K.
Summit Trail Advisors first reported a position in BioSpecifics Technologies Corp. in Q4 2017 and held it in 3 quarters.
Summit Trail Advisors's BioSpecifics Technologies Corp. position peaked at $295K in Q4 2017.
107 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2018.

Based on Summit Trail Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.